(Q36565562)

15 August 2017

1 reference

title

Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis (English)

1 reference

15 August 2017

0 references

Kwok C Chang

1

1 reference

15 August 2017

Chi C Leung

2

1 reference

15 August 2017

Wing W Yew

3

1 reference

15 August 2017

Shiu L Chan

4

1 reference

15 August 2017

Cheuk M Tam

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

14 August 2006

1 reference

American Journal of Respiratory and Critical Care Medicine

15 August 2017

published in

1 reference

15 August 2017

volume

174

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

1153-1158

1 reference

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-637OC

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-637OC

A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-637OC

Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200605-637OC

10.1164/RCCM.200605-637OC

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference